Febuxostat
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1667 publications
Controversies in Urate-Lowering Therapy for Gout: A Comprehensive Review.
Journal: Gout, urate, and crystal deposition disease
Published: August 18, 2026
Real-World Effectiveness and Safety of Dotinurad in Chinese Patients with Gout: A Comparative Analysis.
Journal: Drugs - real world outcomes
Published: July 17, 2026
Reconsidering Urate-Lowering Therapy in Chronic Kidney Disease- Guideline Driven Perspectives on the Management of Asymptomatic Hyperuricaemia.
Journal: JPMA. The Journal of the Pakistan Medical Association
Published: June 27, 2026
Cinnamaldehyde Attenuates Hyperuricemia-Associated Renal Injury by Modulating Urate Transporters and AIF1- and CMPK2/NLRP3-Related Inflammatory Signaling.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 25, 2026
Synthesis of Primary Thioamides by the Insertion of CS2 into Aldoximes.
Journal: Organic letters
Published: June 08, 2026
Febuxostat enhances the anti-tumor efficacy of 2-fluoroadenine and 5'-methylthioadenosine in MTAP-deleted cancer.
Journal: bioRxiv : the preprint server for biology
Published: June 04, 2026
Green Sensitive Derivative Emission Spectrofluorimetry for the Estimation of Repaglinide and Febuxostat Simultaneously in Dosage Forms and Spiked Human Plasma.
Journal: Luminescence : the journal of biological and chemical luminescence
Published: June 02, 2026
Correction: Comprehensive Review on Febuxostat for Hyperuricemia with Gout: Insights from Current Practice and Clinical Trials.
Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: May 18, 2026
The Dual Role of Uric Acid: Pathological Implications Across Chronic Diseases and Current Approaches to Hyperuricemia Management.
Journal: Discoveries (Craiova, Romania)
Published: May 16, 2026
Last Updated: 09/26/2026